Opening the Floodgates to T Cells – Biomarkers for the Combination of Bevacizumab and Atezolizumab in RCC
Jeffrey Wallin, Ph.D. of Genentech presents "Opening the Floodgates to T Cells – Biomarkers for the Combination of Bevacizumab and Atezolizumab in RCC" at the 14th International Kidney Cance...
Author: kidneycancer
Added: 11/07/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts